November 01, 2014 8:42 AM ET

Life Sciences Tools and Services

Company Overview of ProteinSimple

Executive Profile

Timothy A. Harkness

Former Chief Financial Officer and Senior Vice President, Nektar Therapeutics
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 7 different industries.

See Board Relationships
47--

Background

Mr. Timothy A. Harkness, also known as Tim, served as the President and Chief Executive Officer of ProteinSimple since June 2008. Mr. Harkness is an experienced executive in the technology field. He served in management positions for private and international companies in various sectors of the technology industry. He served as the Chief Financial Officer and Senior Vice President of Finance of Nektar Therapeutics from August 23, 2007 to December 2007. Mr. Harkness ...

Corporate Headquarters

3040 Oakmead Village Drive
Santa Clara, California 95051

United States

Phone: 408-510-5500
Fax: 408-510-5599

Board Members Memberships

Director
Director
2008-2010
Former Director and Chairman of Audit Committee
2008-N/A
Former Chief Executive Officer, President and Director
2010-Present
Director, Chairman of Audit Committee and Member of Governance & Nominating Committee

Education

MBA
Stanford Graduate School of Business
Bachelor's Degree
University of Wisconsin - Madison
MBA
The Leland Stanford Junior University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Aguiar Chief Executive Officer, President and Director
Theravance Inc.
$515.4K
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ProteinSimple, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.